Stay updated on Nivolumab Combo in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Head & Neck Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page reflects an update to the site’s revision version from v3.5.2 to v3.5.3, indicating an underlying platform/admin release rather than content changes to the trial record.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.5.2 was added; Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision notes show the addition of v3.5.0 and removal of v3.4.3.SummaryDifference0.1%

- Check50 days agoChange DetectedThe revision tag on the page was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check64 days agoChange DetectedThe sponsor and affiliated institution names were updated to the official designation: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The page now lists Thomas Jefferson University (Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University) and removes the alternate aliases to standardize naming.SummaryDifference0.3%

- Check79 days agoChange DetectedFooter updated to revision v3.4.2 (from v3.4.1); no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Head & Neck Cancer Clinical Trial page.